Novo Nordisk A/S (NYSE:NVO)

111.59
Delayed Data
As of Jul 01
 +0.16 / +0.14%
Today’s Change
83.86
Today|||52-Week Range
122.16
-0.37%
Year-to-Date

Stock Price Forecast

The 25 analysts offering 12-month price forecasts for Novo Nordisk A/S have a median target of 123.24, with a high estimate of 144.36 and a low estimate of 75.43. The median estimate represents a +10.44% increase from the last price of 111.59.

Analyst Recommendations

The current consensus among 30 polled investment analysts is to Buy stock in Novo Nordisk A/S. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.84
Sales
$5.8B
Reporting Date
Aug 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -5.11%
 
 
 
 
 
 
Growthannually 7.56%
 
 
 
 
 
 

Sales

Growthquarterly -2.78%
 
 
 
 
 
 
Growthannually 12.33%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.